» Articles » PMID: 39710824

Comparative Analysis of Human Brain RNA-seq Reveals the Combined Effects of Ferroptosis and Autophagy on Alzheimer's Disease in Multiple Brain Regions

Overview
Journal Mol Neurobiol
Date 2024 Dec 22
PMID 39710824
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis and autophagy are closely associated with Alzheimer's disease (AD). Elevated ferric ion levels can induce oxidative stress and chronic inflammatory responses, resulting in brain tissue damage and further neurological cell damage. Autophagy in Alzheimer's has a dual role. On one hand, it protects neurons by removing β-amyloid and cellular damage products caused by oxidative stress and inflammation. On the other hand, abnormal autophagy is linked to neuronal apoptosis and neurodegeneration. However, the intricate interplay between ferroptosis and autophagy in AD remains insufficiently explored. This study focuses on the roles of ferroptosis and autophagy in AD and their interconnection through bioinformatics analysis, shedding light on the disease. Ferroptosis and autophagy significantly correlate with the development and course of AD. Using PPI network analysis and unsupervised consistency clustering analysis, we uncovered a complex network of interactions between ferroptosis and autophagy during disease progression, demonstrating a significant congruence in their modification patterns. Functional analyses further demonstrated that ferroptosis and autophagy together affect the immunological status and synaptic regulation in hippocampal regions in patients with AD, which significantly impacts the start and progression of the disease.

Citing Articles

Maladaptive changes in the homeostasis of AEA-TRPV1/CB1R induces pain-related hyperactivity of nociceptors after spinal cord injury.

Hu J, Fan W, Xu Y, Li X, Zhang H, Li S Cell Biosci. 2025; 15(1):2.

PMID: 39789637 PMC: 11720958. DOI: 10.1186/s13578-025-01345-6.

References
1.
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E . Alzheimer's disease. Lancet. 2011; 377(9770):1019-31. DOI: 10.1016/S0140-6736(10)61349-9. View

2.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

3.
Graff-Radford J, Yong K, Apostolova L, Bouwman F, Carrillo M, Dickerson B . New insights into atypical Alzheimer's disease in the era of biomarkers. Lancet Neurol. 2021; 20(3):222-234. PMC: 8056394. DOI: 10.1016/S1474-4422(20)30440-3. View

4.
Dolgin E . This is how an Alzheimer's gene ravages the brain. Nature. 2022; 611(7937):649. DOI: 10.1038/d41586-022-03724-2. View

5.
Wang D, Hui Y, Peng Y, Tang L, Jin J, He R . Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J Alzheimers Dis. 2014; 43(2):519-34. DOI: 10.3233/JAD-140567. View